Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic Regions

被引:9
作者
Economopoulou, Panagiota [1 ]
Pantazopoulos, Anastasios [1 ]
Spathis, Aris [2 ]
Kotsantis, Ioannis [1 ]
Kyriazoglou, Anastasios [1 ]
Kavourakis, George [1 ]
Zakopoulou, Roubini [1 ]
Chatzidakis, Ioannis [1 ]
Anastasiou, Maria [1 ]
Prevezanou, Maria [1 ]
Resteghini, Carlo [3 ]
Licitra, Lisa [3 ,4 ]
Bergamini, Cristiana [3 ]
Colombo, Elena [3 ]
Caspani, Francesca [3 ]
Denaro, Nerina [5 ]
Vecchio, Stefania [6 ]
Bonomo, Pierluigi [7 ]
Cossu Rocca, Maria [8 ]
Bertolini, Federica [9 ]
Ferrari, Daris [10 ]
Psyrri, Amanda [1 ]
Bossi, Paolo [11 ]
机构
[1] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Internal Med 2, Sect Med Oncol, Athens 12462, Greece
[2] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Pathol 2, Athens 12462, Greece
[3] Fdn IRCCS Ist Nazl Tumori, Head & Neck Med Oncol Unit, Via Venezian 1, I-20133 Milan, Italy
[4] Univ Milan, Dept Oncol & Hematooncol, I-20122 Milan, Italy
[5] Med Oncol Santa Croce & Carle Gen Hosp Cuneo, I-12100 Cuneo, Italy
[6] IRCCS Osped Policlin San Martino, I-16132 Genoa, Italy
[7] Azienda Osped Univ Careggi, Radiat Oncol, I-50134 Florence, Italy
[8] European Inst Oncol IRCCS, Dept Med Oncol Urogenital & Head & Neck Tumors Me, IEO, I-20141 Milan, Italy
[9] Univ Hosp Modena, Dept Hematol & Oncol, Med Oncol Unit, I-41125 Modena, Italy
[10] San Paolo Hosp, Med Oncol Unit, I-20142 Milan, Italy
[11] Univ Brescia, ASST Spedali Civili, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Med Oncol, I-25123 Brescia, Italy
关键词
immunotherapy; nasopharyngeal cancer; EBV DNA; nonendemic region; ANTITUMOR-ACTIVITY; PHASE-II; RECURRENT; CHEMOTHERAPY; MULTICENTER; PEMBROLIZUMAB; CAMRELIZUMAB; BIOMARKERS; CANCER; SAFETY;
D O I
10.3390/cells11010032
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: nasopharyngeal carcinoma (NPC) is a complex disease entity that mainly predominates in endemic regions. Real-world data with immunotherapy from nonendemic regions are limited. Methods: we collected data from patients with recurrent/metastatic (R/M) NPC treated at a center in Greece and 8 centers in Italy. Between 2016 and 2021, 46 patients who were treated with at least one cycle of immune checkpoint inhibitors (ICI) were identified. Herein, we present our results and a review of the literature. Results: assessment of response was available in 42 patients. Overall, 11 patients responded to immunotherapy (Overall Response Rate-ORR 26.2%). Three patients had complete response (CR), and 8 patients had partial response (PR). Disease control rate (DCR) was 61.9%. Median Progression Free Survival (PFS) was 5.6 months and median Overall Survival (OS) was 19.1 months. Responders to ICI improved PFS and OS as compared to that of nonresponders. A lower probability of responding to ICI was shown in patients with more than three metastatic sites (p = 0.073), metastatic disease at initial diagnosis, (p = 0.039) or EBV DNA positive before ICI initiation, (p = 0.074). Decline in EBV DNA levels was found to be statistically significant associated with best response to ICI (p = 0.049). Safety was manageable. Conclusions: among 46 patients with R/M NPC treated with immunotherapy in two nonendemic regions, ORR was 26.2% and durable responses were observed. Low disease burden could serve as a biomarker for response to ICI.
引用
收藏
页数:10
相关论文
共 50 条
[41]   Plasma EBV estimation in Nasopharyngeal carcinoma from a nonendemic region: Impact of probe assay type, EBV copy numbers as a predictive and prognostic marker. [J].
Laskar, Sarbani Ghosh ;
Sinha, Shwetabh ;
Kumar, Anuj ;
Mohanty, Samarpita ;
Prabhash, Kumar ;
Chougule, Anuradha ;
Shetty, Omshree ;
Singla, Aarushi ;
Khondekar, Naziba Karim ;
Swain, Monali ;
Budrukkar, Ashwini .
RADIOTHERAPY AND ONCOLOGY, 2024, 192 :S255-S256
[42]   Avelumab maintenance in advanced urothelial carcinoma: real-world data from Northern Spain (AVEBLADDER study) [J].
Sotelo, Marta ;
Pelaez, Mireia ;
Basterretxea, Laura ;
Varga, Estrella ;
Sanchez-Escribano, Ricardo ;
Pujol Obis, Eduardo ;
Santander, Carmen ;
Martinez Kareaga, Mireia ;
Arruti Ibarbia, Mikel ;
Rodriguez Ledesma, Inmaculada ;
Alvarez Fernandez, Carlos ;
Piedra, Pablo ;
Calderero Aragon, Veronica ;
Lainez, Nuria ;
Verdun Aguilar, Juan Antonio ;
Gil Arnaiz, Irene ;
Fernandez, Ricardo ;
Mazas, Cristina ;
Duran, Ignacio .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
[43]   Collection of real-world data on nivolumab's effectiveness in renal cell carcinoma: rationale for an observational study [J].
Bedke, Jens ;
Grimm, Marc-Oliver ;
Gruenwald, Viktor .
FUTURE ONCOLOGY, 2018, 14 (11) :1023-1034
[44]   Efficacy and Adverse Events of PD-1 Inhibitors in Patients With Advanced Urothelial Carcinoma From a Real-World Experience [J].
Sun, Fengze ;
Wang, Dawei ;
Liu, Aina ;
Wang, Tianqi ;
Zhang, Dongxu ;
Yao, Huibao ;
Sun, Kai ;
Zhou, Zhongbao ;
Lu, Guoliang ;
Wu, Jitao .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[45]   Immunotherapy for NSCLC With Brain Metastases: What Can We Learn From Real-World Data? [J].
Kouno, Shunichi ;
Atagi, Shinji .
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (07) :1119-1121
[46]   Real-World Data from a Spanish Institution [J].
Zwisler-Contreras, P. ;
Ramos, I. ;
Guardamagna, M. ;
Ithurbisquy, C. ;
Oliva, L. ;
Ruiz, S. ;
Alba, E. .
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) :S580-S581
[47]   Effect of chemotherapy alone or combined with immunotherapy for locally advanced or metastatic genitourinary small cell carcinoma: a real-world retrospective study [J].
Huang, Riqing ;
Chen, Meiting ;
Li, Haifeng ;
An, Xin ;
Xue, Cong ;
Hu, Anqi ;
Shu, Ditian ;
Yang, Wei ;
Zhou, Fangjian ;
Sui, Dan ;
Yao, Kai ;
Li, Yonghong ;
Wu, Zhiming ;
Li, Zhiyong ;
Liu, Zhuowei ;
Shi, Yanxia .
BMC CANCER, 2023, 23 (01)
[48]   Effects of locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A real-world study [J].
Zeng, Fujuan ;
Lu, Tianzhu ;
Xie, Fei ;
Chen, Lizhi ;
Zhang, Lin ;
Su, Yong ;
Yu, Zhongren ;
Xiao, Yun ;
Ao, Fan ;
Li, Guoqing ;
Chen, Zhiping ;
Gong, Xiaochang ;
Li, Jingao .
TRANSLATIONAL ONCOLOGY, 2021, 14 (11)
[49]   Real-World Experience of Immunotherapy from India in Recurrent Squamous Cell Carcinoma of Head and Neck Cancer [J].
Abbas, Waseem ;
Gupta, Saurabh ;
Goel, Vineeta ;
Rao, Ranga R. ;
Pankaj, Promila ;
Tripathi, Devashish ;
Patil, Pratik P. ;
Popli, Swati .
SOUTH ASIAN JOURNAL OF CANCER, 2021, 10 (02) :72-75
[50]   The real-world treatment characteristic and efficacy of immune checkpoint inhibitors in non-small cell lung cancer: Data from a retrospective cohort study [J].
Zhang, Chenyang ;
Shao, Jun ;
Tang, Xiaolong ;
Wu, Jiayang ;
Li, Peiyi ;
Li, Weimin ;
Wang, Chengdi .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 134